Fluence, a provider of LED lighting solutions for commercial cannabis and food production, has extended its research partnership with Dutch organisation Innexo BV.
Innexo and Fluence on the cannabis market
Fluence Bioengineering, Inc. develops potent and energy-efficient LED lighting systems for industrial crop production and research applications. Its worldwide headquarters are in Austin, Texas, while its EMEA headquarters are in Rotterdam, the Netherlands. It works as a business unit within Signify’s Digital Solutions division.
Innexo BV, however, is based in the Netherlands. It is an organisation that specialises in agricultural contract research with a focus on molecular farming and medicinal plants. It is part of the Botany Group of companies.
Cannabis research partnership between Innexo and Fluence
Firstly, the partnership intends to assist Innexo’s new Acceleration Platform for Innovation (API) program. Through this program, creative small-scale cannabis businesses can study the cultivation of medical cannabis. API participants are, among others, biostimulant and fertiliser producers. Using Fluence’s VYPR Broad R4 LED system, they will be able to conduct research experiments concentrating on plant health and resilience.
Innexo and Fluence began collaborating together in October 2022. At that time, they looked at the effects of top lighting versus intra-canopy lighting on medical cannabis plants.
The growth of the legal cannabis industry in Europe has opened more opportunities and increased the demand for information about cannabis cultivation. The tools required for research investigation, however, are frequently missing. Fluence wants to make it easier for people to get access to tools that stimulate innovation in cannabis production.
According to the comments, Fluence’s experience in science-backed product development, in combination with Innexo’s research in the cannabis area, will provide valuable guidance. Additionally, it will speed up the process by which individuals create intellectual property through research trials.